NM-108

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameNM-108
Drug Alias NameNM108
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionMetalloproteases inhibitorsInflammation mediator inhibitorsCollagenase inhibitors
TargetsMetalloproteasesCollagenase
Therapy Area/IndicationsDiabetic macular oedemaUveitisDiabetic Retinopathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuMedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuMedics Inc
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaUveitisDiabetic Retinopathy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A